Clinical Trials Logo

Clinical Trial Summary

Acute myocardial infarction (AMI) is one of the leading causes of death around the world, with the potential for substantial morbidity and mortality. The increasing evidence indicates that exercise training has beneficial effects on LV remodelling in post-MI patients with greater benefits occurring when training earlier following MI, among which the earliest time for rehabilitation is one week after myocardial infarction. However, the effect of Baduanjin sequential therapy for patients after one week of AMI has yet to be assessed. Therefore, the aim of this study is to assess the impact of Baduanjin sequential therapy on cardiac and physical function in patients with AMI and reduced ejection fraction after primary PCI.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05201274
Study type Interventional
Source Shenyang Northern Hospital
Contact Meili Liu, MD
Phone 86-18940193302
Status Recruiting
Phase N/A
Start date November 11, 2021
Completion date February 11, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT02793934 - The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
Recruiting NCT05122455 - Effects of Edoxaban on Platelet Aggregation Phase 2/Phase 3
Completed NCT00289237 - Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease N/A
Completed NCT00331578 - Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent Phase 4
Recruiting NCT05764057 - DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Phase 3
Recruiting NCT04485988 - Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction
Not yet recruiting NCT06438315 - SuperSaturated Oxygen Comprehensive Observational Registry
Terminated NCT00670228 - Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction Phase 3